An ethnopharmacological study of medicinal plants in New South Wales

Molecules

Volumn 10, Issue 10, 2005, Pages 1252-1262

  Brouwer, Nynke ^a,b   Liu, Qian ^a,b   Harrington, David ^a   Kohen, James ^a   Vemulpad, Subramanyam ^a   Jamie, Joanne ^a   Randall, Michael ^b   Randall, Deidre ^b  

^a MACQUARIE UNIVERSITY   (Australia)

^b Yaegl Land Council   (Australia)

Author keywords

Aboriginal medicine; Bioassay guided fractionation; Ethnobotany; Ethnopharmacology; Natural products

Indexed keywords

3',6' DIACETYLFLUORESCEIN; 3',6'-DIACETYLFLUORESCEIN; FLUORESCEIN DERIVATIVE; OXAZINE DERIVATIVE; PLANT EXTRACT; RESAZURIN; XANTHENE DERIVATIVE;

ANIMAL; AUSTRALIA; BIOLOGICAL MODEL; CHEMISTRY; CONFERENCE PAPER; DRUG EFFECT; HUMAN; MEDICINAL PLANT; MICROBIOLOGICAL EXAMINATION; OOCYTE; TRADITIONAL MEDICINE; XENOPUS;

ANIMALS; AUSTRALIA; FLUORESCEINS; HUMANS; MEDICINE, TRADITIONAL; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; OOCYTES; OXAZINES; PLANT EXTRACTS; PLANTS, MEDICINAL; XANTHENES; XENOPUS;

EID: 33644804628     PISSN: 14203049     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/10101252     Document Type: Conference Paper

References (35)

1. Aboriginal Communities of the Northern Territory of Australia. Traditional Bush Medicines: An Aboriginal Pharmacopoeia; Greenhouse Publications: Richmond, 1988; pp 8-10.
2. Smith, N.M. Ethnobotanical Field Notes from the Northern Territory. J. Adelaide Bot. Gard. 1991, 14, 1-65.
3. World Health Organisation. Traditional Medicine Strategy 2002-2005; WHO: Geneva, 2002; see http://www.who.int/medicines/library/trm/trm_strat_eng.pdf. Last accessed 26/11/2004.
4. Davis, E.W. Ethnobotany: An Old Practice, A New Discipline. In: Schultes, R.E.; Reis, S. von. Ethnobotany: Evolution of a Discipline; Chapman & Hall / Dioscorides Press: London, 1995; pp. 40-49.
5. Reid, E.J.; Betts, T.J. Records of Western Australian Plants Used by Aboriginals as Medicinal Agents. Planta Med. 1979, 36, 164-173.
6. Gott, B. NSWUSE-Database of NSW Plants Utilised by Aborigines. Lodged at the Australian Institute of Aboriginal and Torres Strait Islander Studies (AIATSIS) Library, 1996.
7. National Health and Medical Research Council. Values and Ethics: Guidelines for Ethical Conduct in Aboriginal and Torres Strait Islander Health Research. Commonwealth of Australia: Canberra, 2003; see: http://www.nhmrc.gov. au/publications/pdf/e52.pdf. Last accessed 13/04/2005.
8. United Nations Environment Program. Traditional Knowledge and the Convention on Biological Diversity. Secretariat to the Convention on Biological Diversity: Montreal, 1993.
9. Tuxill, J.; Nabhan, G.P. People, Plants and Protected Areas: a guide to in situ management. UNESCO / Earthscan: London, 2001.
10. Farnsworth, N.R. Ethnopharmacology and drug development. In: Prance, G.T.; Chadwick, D.J.; Marsh, J. (eds.) Ethnobotany and the search for new drugs, Ciba Foundation Symposium 185; Wiley: New York, 1994; pp. 42-51.
11. Latz, P. quoted in Lassak, E.V.; McCarthy, T. Australian Medicinal Plants; New Holland Publishers: Sydney, 2001; p. 14.
12. Fabricant, D.S.; Farnsworth, N.R. The Value of Plants Used in Traditional Medicine for Drug Discovery. Environ. Health Persp. 2001, 109 (suppl. 1), 69-75.
13. Balick, M.J.; Cox, P.A. Plants, People, and Culture: The Science of Ethnobotany; Scientific American Library: New York, 1997; pp. 56-57.
14. World Health Organisation. Fact sheet No. 194; WHO: Geneva, Revised January 2002; see http://www.who.int/mediacentre/factsheets/fs194/en/print.html. Last accessed 26/11/2004.
15. World Health Organisation. Fact sheet No. 265; WHO: Geneva, December 2001; see http:/www.who.int/mediacentre/factsheets/fs265/en/print.html. Last accessed 26/11/2004.
16. Antuono, P.; Beyer, J. The Burden of Dementia: A Medical and Research Perspective. Theor. Med. 1999, 20, 3-13.
17. Australian Institute of Health and Welfare. Australia's Health 2000; AIHW: Canberra, 2000; pp. 97-102.
18. Houghton, P.J.; Roman, A. Laboratory Handbook for the Fractionation of Natural Extracts; Chapman & Hall: London, 1998.
19. Straton, C.W.; Cooksey, R.C. Susceptibility Tests: Special Tests. In: Balows, A. (ed.) Manual of Clinical Microbiology; American Society for Microbiology: Washington, 1991; pp. 1153-1165.
20. Barry, A.L.; Thorsnberry, C. Susceptibility Tests: Diffusion Test Procedures. In: Balows, A. (ed.) Manual of Clinical Microbiology; American Society for Microbiology: Washington, 1991; pp. 1117-1125.
21. O'Brien, J.; Wilson, I.; Orton, T.; Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000, 267, 5421-5426.
22. Mann, C.M.; Markham, J.L. A new method for determining the minimum inhibitory concentration of essential oils. J. Appl. Microbiol. 1998, 84, 538-544.
23. Wanandy, S.; Brouwer, N.; Liu, Q.; Mahon, A.; Cork, S.; Karuso, P.; Vemulpad, S.; Jamie, J. Optimisation of the fluorescein diacetate antibacterial assay. J. Microbiol. Methods. 2005, 60, 21-30.
24. Chand, S.; Lusunzi, I.; Veal, D.A.; Williams, L.R.; Karuso, P. Rapid Screening of the Antimicrobial Activity of Extracts and Natural Products. J. Antibiot. 1994, 47, 1295-1304.
25. Brunius, G. Technical Aspects of the Use of 3',6'-Diacetyl Fluorescein for Vital Fluorescent Staining of Bacteria. Curr. Microbiol. 1980, 4, 321-323.
26. Chebib, M.; Johnston, G.A.R. GABA-Activated Ligand Gated Ion Channels: Medicinal Chemistry and Molecular Biology. J. Med. Chem. 2000, 43, 1427-1447.
27. Schnizler, K.; Küster, M.; Methfessel, C.; Fejtl, M. The Roboocyte: Automated cDNA/mRNA Injection and Subsequent TEVC Recording on Xenopus Oocytes in 96-Well Microtiter Plates. Receptor. Channel. 2003, 9, 41-48.
28. Voet, D.; Voet, J.G. Biochemistry; Wiley: New York, 1995; 704-710.
29. Dubois, R.N.; Abramson, S.B.; Crofford, L.; Gupta, R.A.; Simon, L.S.; Putte, L.B.A. van de; Lipsky, P.E. Cyclooygenase in biology and disease. FASEB J. 1998, 12, 1063-1073.
30. Chandrasekharan, N.V.; Dai, H.; Roos, K.L.T.; Evanson, N.K.; Tomsik, J.; Elton, T.S.; Simmons, D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic dugs: Cloning, structure, and expression. Proc. Natl. Acad. Sci. 2002, 99, 13926-13931.
31. Bertolini, A.; Ottani, A. ; Sandrini, M. Selective COX-2 Inhibitors and Dual Acting Anti-inflammatory Drugs: Critical Remarks; Curr. Med. Chem. 2002, 9, 1033-1043.
32. Wu, K.K. Biochemical Pharmacology of Nonsteroidal Anti-Inflammatory Drugs. Biochem. Pharmacol. 1998, 55, 543-547.
33. Topol, E.J. Arthritis Medicines and Cardiovascular Events - "House of Coxibs". J. Am. Med. Assoc. 2005, 293, 366-368.
34. Cayman Chemical, COX Inhibitor Screening Assay, Catalog No. 560131. Ann Arbor, MI 48108, USA.
35. Cayman Chemical, Lipoxygenase Inhibitor Screening Assay Kit, Catalog No. 760700. Ann Arbor, MI 48108, USA